Abstract
This retrospective study describes the effects of long-term treatment with melatonin in 33 adolescents (age range, 10-18 years) with delayed sleep phase syndrome (DSPS). Patients were treated with oral melatonin, 3 to 5 mg/day for an average period of 6 months. During the treatment, sleep onset was advanced and sleep duration was longer. Treatment was also associated with a decrease in the proportion of patients reporting school difficulties. No adverse effects of melatonin were noted. This study indicates that long-term treatment with melatonin can be beneficial for adolescents with DSPS in terms of sleep-wake schedule and school performance.
MeSH terms
-
Administration, Oral
-
Adolescent
-
Age Factors
-
Analysis of Variance
-
Attention Deficit Disorder with Hyperactivity / complications
-
Attention Deficit Disorder with Hyperactivity / drug therapy
-
Case-Control Studies
-
Child
-
Circadian Rhythm / drug effects
-
Female
-
Follow-Up Studies
-
Humans
-
Israel
-
Male
-
Melatonin / administration & dosage
-
Melatonin / therapeutic use*
-
Psychomotor Performance / drug effects
-
Research Design
-
Retrospective Studies
-
Sleep / drug effects
-
Sleep Disorders, Circadian Rhythm / complications
-
Sleep Disorders, Circadian Rhythm / diagnosis
-
Sleep Disorders, Circadian Rhythm / drug therapy*
-
Time Factors
-
Treatment Outcome
-
Wakefulness / drug effects